2012-17554. Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Examination of Online Direct-to-Consumer Prescription Drug Promotion
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Examination of Online Direct-to-Consumer Prescription Drug Promotion” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Juanmanuel Vilela, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-7651, Juanmanuel.Vilela@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
On January 31, 2012, the Agency submitted a proposed collection of information entitled “Examination of Online Direct-to-Consumer Prescription Drug Start Printed Page 42501Promotion” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0714. The approval expires on July 31, 2015. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.
Start SignatureDated: July 12, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-17554 Filed 7-18-12; 8:45 am]
BILLING CODE 4160-01-P
Document Information
- Comments Received:
- 0 Comments
- Published:
- 07/19/2012
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2012-17554
- Pages:
- 42500-42501 (2 pages)
- Docket Numbers:
- Docket No. FDA-2011-N-0230
- PDF File:
- 2012-17554.pdf
- Supporting Documents:
- » Reference 1 - Macias, W. and L. Stavchansky Lewis, "How Well Do Direct-to-Consumer (DTC) Prescription Drug Web Sites Meet FDA Guildlines and Public Policy Concers?" Health Marketing Quarterly, vol.22, pp. 45-71, 2005 re FDA-2011-N-0230-0001
- » See FDA-2011-N-0230-0006